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Abstract 
The reaction mechanisms of p-nitrophenyl phosphate hydrolysis catalyzed by two rat liver isoenzymes of the low M, phosphotyrosine 
protein phosphatase (AcPl and AcP2) were compared. Furthermore, the effect of some heterocyclic compounds on their activities were 
tested. Cyclic GMP and guanosine causes a particularly high activation of the isoenzyme AcP2, whereas its effect on AcPl is very poor. 
.A study on the mechanism of cyclic GMP activation was carried out. The results suggest that cyclic GMP activates the AcP2 isoenzyme 
hy increasing the rate of the step that leads to the hydrolysis of the covalent enzyme-substrate phosphorylated complex formed during the 
catalytic process. The physiological significance of cyclic GMP activation of only one of the two isoenzymes (AcP2) remains uncertain. 
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1. Introduction 
Protein tyrosine phosphorylation plays a crucial role in 
the regulation of cell proliferation. Several phospho- 
tyrosine protein kinases are involved in growth control and 
in cell transformation. The cellular phosphotyrosine level 
is regulated by the relative activities of opposing phospho- 
tyrosine protein kinases and phosphotyrosine protein phos- 
phatases (PTPases). PTPases are a family of enzymes that 
have no structural homology with the Ser/Thr-protein 
phosphatases. They are divided into two subfamilies [1,2]. 
The first one includes the receptor-like enzymes, whereas 
the other includes the non-receptor-like enzymes. The 
extracellular domains of the receptor-like PTPases LAR, 
DLAR, DPTP are homologous to cell adhesion molecules 
[.i] and it was suggested that the interaction of these 
Abbreviations: PTPase, phosphotyrosine protein phosphatase; AcPl 
and AcP2, rat liver phosphotyrosine protein phosphatse isoenzymes; 
cGMP, cyclic GMP; pNPP, p-nitrophenyl phosphate 
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receptor-like PTPases with the neighboring cells may serve 
as signal to activate their PTPase cytosolic domains, pro- 
ducing a counteraction against the phosphotyrosine protein 
kinases. Streuli [4] suggested that this mechanism is in- 
volved in the contact inhibition of cell growth. Nothing is 
known about the regulation of non-receptor-like PTPases. 
This paper deals with the activation of a particular 
PTPase (E.C. 3.1.3.48), which was previously studied as 
an acid phosphatase (E.C. 3.1.3.2) by some purine com- 
pounds, particularly cGMP. This enzyme is localized in 
the cytosol and has a A4, of 18000. Two isoenzymes that 
differ in residues 40-73 of the sequences have been 
isolated from both human erythrocytes and rat liver [5,6]. 
They probably originated from a single gene through an 
alternative splicing mechanism. We and other authors have 
recently demonstrated that this enzyme possesses a spe- 
cific PTPase activity versus Tyr-phosphorylated protein 
and peptide substrates [7-111, and no activity on Ser-phos- 
phorylated casein [lo]. The enzyme catalyzes the hydroly- 
sis of substrates by forming a thiol-phosphate covalent 
intermediate [12]. The hydrolysis of this intermediate is the 
limiting step of the catalytic process [13]. The same reac- 
tion mechanism is common exclusively to that of the 
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PTPase family members [1,2,14,15], and different from 
that shared by the acid and alkaline phosphatases [16]. 
2. Materials and methods 
Low M, PTPase isoenzymes from rat liver (AcPl and 
AcP2) were purified as previously described [6]. p- 
Nitrophenyl phosphate, phenyl phosphate, 2-naphthyl 
phosphate, L-phosphotyrosine, GMP, GDP, GTP, ATP, 
CMP, UMP, cGMP, CAMP, adenosine and guanosine were 
purchased from Sigma, St. Louis, MO. All other reagents 
were the purest commercially available. 
2.1. Enzyme assay and transphosphorylation 
The activity on p-nitrophenyl phosphate, phenyl phos- 
phate, 2-naphthyl phosphate and L-phosphotyrosine was 
determined as follows: substrates were dissolved in 0.1 M 
sodium acetate buffer (pH 5.5) containing 1 mM EDTA. 
The reaction was started by adding small volumes of 
enzyme (final volume = 1 ml, 37°C) and stopped by adding 
1 ml of 1 M NaOH. The phenols produced were measured 
spectrophotometrically by using the following extinction 
coefficients: .s4a0 = 18 000 M-‘cm-‘, p - nitrophenol 
b71; E287 = 2560 M-‘cm-‘, phenol [13]; e346 = 2780 
M-‘cm-‘, 2 - naphthol [13]; ??zg3.s = 2330 M-‘cm-‘, 
phosphotyrosine [18], all in alkaline solution. The extent of 
transphosphorylation from p-nitrophenyl phosphate to 
glycerol or methanol were estimated by measuring, in the 
same reaction mixture, the release of either p-nitrophenol 
or the release of Pi using the method of Baginski et al. 
b91. 
2.2, Kinetic model for enzyme activation by cGh4P 
Zhang and Van Etten [13] proposed the following mini- 
mal scheme for the p-nitrophenyl phosphate hydrolysis 
catalyzed by the low M, PTPase from bovine heart: 
E+!&E& E-P $E+P. I (Scheme 1) 
k, + ROH 
where E-P is a phosphorylated enzyme covalent com- 
plex. Taken into account that k, z=- k, and that the 
hydrolysis of the E-P covalent complex is the limiting step 
of the process [13], the kinetics of this type of process are 
formally described by the usual Michaelis-Menten two- 
steps scheme (Berezin et al. [20], Dissing et al. 1211): 
E+&ESkzE+Pi+ROH (Scheme 2) 
where K, = k_ ,/k, is the true equilibrium dissociation 
constant of the enzyme-substrate complex (ES) and k,,, is 
the kinetic constant that leads to generation of products. 
Thus we applied this simple scheme to analyze the activa- 
tion mechanism of rat liver AcP2 by cGMP. The following 
general scheme for non-essential activation (Segel [22]) 
was used (Scheme 3): 
KS k 
E i= S S ES ,“’ E + P 
i 
+ 
A 
ltK* It CIK* 
EA + S % ESA --) EA + P 
a& I&at 
Scheme 3 
where S is the substrate, A is the activator cGMP, P 
represents the products, KA is the dissociation constant of 
the enzyme-cGMP complex (EA) into free enzyme (E) and 
cGMP, CYK~ is the dissociation constant of the enzyme- 
activator-substrate complex (ESA) into EA and S, and 
cxKA is the dissociation constant for the ESA complex into 
ES and A, k,,, is the rate constant for the breakdown of 
ES into products, Pk,,, is the rate constant for the break- 
down of ESA into products. 
The conservation equation for the enzyme is: 
[E,] = [E] + [ES] + [EA] + [ESA] 
The initial rate equation is: 
0 = k,,,[ES] + &,,[ESA] 
Dividing both sides by [Et]: 
u L PSI + Pka, [ES4 - = 
[Et1 [El + [ES1 + [EAI + WA1 
(1) 
(2) 
(3) 
From steady-state assumption for [ES]: 
where (k, = (k_ 1 + k,,,)/k,). Rearranging Eq. (3) 
and substituting for [ES], [EA], and [ESA]: 
kcat[Etl [E] + K K 
PIN + [Elbl + PIPNAI (4) 
m A LYKAK 
canceling E and substituting V,,, for k,,,[E,]: 
u 
- = 
V max 
Km KA ~KAKlll 
(5) 
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then, in Michalis-Menten form, the velocity equation is: 
= 
(1+&l) - - (1+-g) 
Km(l+!!!_l) +~sl(l+!w) 
the reciprocal form of Eqn. (6) is: 
(6) 
(7) 
If a plot of l/v versus l/[S] at different cGMP concen- 
trations is made, a set of straight lines is obtained (see Fig. 
2 below). The l/u axis and l/[S] axis intercepts of the 
limiting plot (at a saturating concentration of activator) 
give l/P V,,, and -l/K, [22]. In the absence of the 
activator Eq. (7) becomes the well - known Lineweaver- 
Burk equation [23]. Clearly, p represents the maximal 
activation at an infinitely high concentration of cGMP. 
2.3. Determination of K,, k, and k, relative to AcPl and 
AcP2. 
The determination of the true enzyme - substrate 
equilibrium dissociation constant (k, = k-,/k,) was 
achieved using a method previously described by Cirri et 
al. [24] and cited herein. This method takes advantage of 
the transphosphorylation properties of the enzyme from the 
substrate and an acceptor molecule that competes with 
water in the attack at the EP covalent complex (glycerol in 
our case). 
3. Results and discussion 
3.1. Kinetic properties of AcPl and AcP2 
The main kinetic properties of both rat liver AcPl and 
AcP2 isoenzymes relative to four substrates have been 
determined (Table 1). It can be seen that AcPl shows K, 
values lower than those of AcP2 with respect to all tested 
substrates. Furthermore AcPl has very similar kcat values 
for the four substrates. On the contrary AcP2 shows simi- 
lar kcat values for p-nitrophenyl phosphate, phenyl phos- 
phate and 2-naphthyl phosphate, but quite a lower value 
for L-phosphotyrosine. Zhang and Van Etten [13,25] 
showed that the bovine heart low M, PTPase, which is 
strictly related to AcP2 [6], has quite constant kcat values 
for structurally differing aryl phosphates, including r_-phos- 
photyrosine, and they concluded that the hydrolysis of all 
tested aryl phosphates proceeds through the same phos- 
phoenzyme covalent intermediate, the hydrolysis of this 
intermediate being the limiting step of the catalytic pro- 
cess. The evidence relative to L-phosphotyrosine was con- 
tradicted by our findings in experiments of phosphotrans- 
fer from L-phosphotyrosine to glycerol [24] catalyzed by 
Table I 
Kinetic parameters of rat liver AcPl and AcP2 isoenzymes. A scheme of the structural differences between AcPl and AcP2 is shown in the bottom. 
p-Nitrophenyl phosphate 
L-Phosphotyrosine 
Phenyl phosphate 
?-Naphthyl phosphate 
k,,, (s - ’ 1 
K, (mM) 
K, (mM) 
k, (s- ‘) 
k, (s- ‘) 
k,,, (s- ’ 1 
K, (mM) 
k,,, (s- ’ 1 
K, (mM) 
k,,, (s- ’ 1 
K, (mM) 
AcPl AcP2 
15.0 29.8 
0.05 0.18 
0.46 5.40 
138 894 
16.8 30.8 
14.6 12.1 
0.55 6.10 
14.8 24.9 
0.49 1.46 
13.8 26.5 
0.06 0.46 
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Table 2 
Effect of some compounds on the activities of the rat liver AcPl and 
AcP2 isoenzymes 
Addition to the Relative activity 
assay mixture AcPl AcP2 
* None lOOk2 100+2 
a Guanosine 99k2 240+6 
a GMP 107i3 128+3 
a GDP lOOk3 120+4 
a GTP 100+2 114k2 
a cGMP 105+3 34Ok8 
’ cGMP + 0.05 M NaCl n.d. 340+6 
a cGMP + 0.1 M NaCl n.d. 330*7 
b cGMP (pH 6.0) n.d. 320&5 
b cGMP (pH 6.5) n.d. 295i6 
’ cGMP (pH 7.0) n.d. 280f4 
a Adenosine 98+1 100+2 
a CAMP 98+1 113+3 
a ATP 99+2 100+2 
a CMP 95k2 96k2 
a UMP loo+1 99k2 
a Assays performed with 4 mM p-nitrophenyl phosphate as substrate at 
37°C and pH 5.5. b The assays in the pH range 6-7 were performed at 
higher p-nitrophenyl phosphate concentrations in order to saturate the 
enzyme, since the Km for this substrate increases with increasing pH. 
The final concentration of each added compound was 0.8 mM; n.d., not 
determined. 
the bovine liver low M, PTPase. In fact we found evi- 
dence that in the L-phosphotyrosine hydrolysis mechanism, 
k, (see Scheme 1) is partly rate-determining [24], even if 
the L value is not significantly different from those of 
the other arylphosphates. L-phosphotyrosine is different 
from other tested aryl phosphates since it has additional 
carboxyl and amino groups that are not present in the other 
substrates tested by Zhang and Van Etten [25]. We sug- 
gested that these groups cause a lowering of the rate of 
enzyme phosphorylation [24]. Clearly, these groups are not 
present in the Tyr-phosphorylated proteins, since they are 
involved in the protein peptide backbone formation. The 
p-nitrophenyl phosphate hydrolysis mechanism, catalyzed 
by both AcPl and AcP2, was studied. Using the method 
described in ‘Materials and Methods’, we were able to 
determine K, (the true enzyme-substrate dissociation con- 
stant) values relative to both AcPl and AcP2. In both cases 
K, is higher than K, (Table 1); this indicates that the 
mechanism of p-nitrophenyl phosphate hydrolysis cat- 
alyzed by both isoenzymes proceeds through an intermedi- 
ate [26]. We also determined the kinetic constants k, and 
k, (see Scheme 1). Table 1 shows the resulting values. It 
can be seen that both AcPl and AcP2 have k, values 
much higher than k, values, suggesting that, in both cases, 
the hydrolysis of E-P is the limiting step of the process. 
3.2. The effect of heterocyclic compounds on AcPl and 
AcP2 
Several authors [27-331 have reported that certain hete- 
rocyclic compounds modulate the activity of low M, PT- 
Pase (previously known as low M, acid phosphatase). 
Table 2 reports the effect of some heterocyclic compounds 
on the activity of both rat AcPl and AcP2 isoenzymes. It 
can be seen that, at a final concentration of 0.8 mM, 
guanosine and cGMP strongly activated the AcP2 isoen- 
zyme (2.4-fold and 3.4-fold, respectively), whereas the 
AcPl isoenzyme was only slightly activated by cGMP. 
Guanosine has no effect on this latter form. The activation 
of AcP2 by cGMP was observed also at different pH 
values in the range 5.5-7.0 and is slightly modified by 
increasing ionic strength (Table 1). Furthermore, the non- 
cyclic nucleotides GMP, GDP and GTP activate AcP2 
1.28-fold, 1.20-fold and l.lCfold, respectively. CAMP 
causes the activation of AcP2 (only 1.13-fold), while the 
other tested purine nucleotide compounds (adenosine and 
ATP) have little or no effect on the activity of both 
enzymes. The effect of the pyrimidine nucleotides CMP 
and UMP on both AcPl and AcP2 activities was negligi- 
ble. The particularly high AcP2 activation elicited by 
cGMP suggested to us to characterize better the activation 
mechanism and to discuss its possible physiological impli- 
cations. 
3.3. Activation mechanism of AcP2 by cGMP 
Fig. 1 shows the activation of AcP2 at increasing 
concentrations of cGMP. It can be seen that the experimen- 
tal points fit well with a hyperbolic curve. The maximal 
activation at infinitely high cGMP concentrations (asymp- 
tote of the curve) can be calculated. In the case of 
p-nitrophenyl phosphate used as substrate, we found a 
value of 6.1 that is the p-coefficient in Scheme 3. 
, [,o...;r _.__.._.._ ‘: . . . . . . . . . .  I .  .  .  .  .  .  .  fF.Ff
0 0.8 1.6 2.4 3.2 
Fig. 1. Effect of cGMP concentration on the activity of AcPl and AcP2 
PTPase isoenzymes. V, is the relative V,,, (taken as unit) in the absence 
of cGMP; V is the relative V,,, in the presence of cGMP at the 
indicated concentrations. 
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Fig. 2. Double reciprocal plot for the hydrolysis of p-nitrophenyl phos- 
phate catalyzed by AcP2 in the presence of increasing concentrations of 
cGMP. The initial rates of p-nitrophenyl phosphate hydrolysis were 
measured at pH 5.5 and 37°C at the indicated concentrations either in the 
absence (m) or presence of (a), 0.1 mM cGMP, and (T 1, 0.2 mM 
cGMP. 
By plotting the reciprocal of the initial rates of p- 
nitrophenyl phosphate hydrolysis at varying concentrations 
of p-nitrophenyl phosphate and cGMP versus the recipro- 
cal of substrate concentration (Eqn. 7) a series of straight 
lines were obtained (Fig. 2). These lines intersect at a point 
in the upper right quadrant. The intersection point has the 
following coordinates : 
1 o-l 
ordinate = - - 
V i 1 
(1 - P) 
max o-P 
; abscissa = - K,(a _ p> 
from which (Y = 7.95 (for p-nitrophenyl phosphate) 
can be calculated. We observe that both (Y and p are > 1 
and that (Y > p. This activation behavior can be classified 
as mixed-type activation as suggested by Segel [22]. 
Fig. 1 also shows that the effect of cGMP on AcPl is 
negligible with respect to that observed for AcP2. The 
former enzyme does not form any complex between the 
free enzyme and cGMP as demonstrated by the spectrum 
showed in Fig. 3, which contains no differential bands. On 
the contrary, AcP2 gave a differential band near 220 nm 
(Fig. 3) confirming the formation of a complex between 
the free AcP2 isoenzyme and cGMP. 
The mechanism of glycerol activation of the low M, 
PTPase from bovine liver has been previously studied [24]. 
We found that the activation is caused by the interaction of 
glycerol with the E-P covalent complex. Glycerol directly 
attacks the E-P covalent complex (see Scheme 3) leading 
to phosphoglycerol(s) formation without affecting the Pi 
production rate, since the k, kinetic constant is much 
higher than the k, constant, leading to the accumulation of 
the E-P covalent complex [24]. This is not what we have 
found with cGMP. Table 3 reports the results relative to 
the p-nitrophenol/P, ratio produced by the enzyme action 
in the presence of glycerol or cGMP. It can be seen that 
there is no transphosphorylation from p-nitrophenyl phos- 
phate to cGMP, since the p-nitrophenol/P, ratio remains 
near the unit both in the absence and presence of cGMP. 
Clearly glycerol increases the enzyme activity through 
transphosphorylation as was previously found [24] . 
Table 3 also reports the results of enzyme activation in 
the presence of both cGMP and glycerol. By increasing the 
cGMP concentration at a fixed concentration of glycerol (1 
M), a decrease of tranphosphorylation from the substrate 
to glycerol was observed. This suggests that cGMP and 
glycerol interact with the enzyme at the same site. Alterna- 
tively the binding of cGMP with the free enzyme or with 
one of the intermediate forms hindered glycerol but not 
water access to the active site. We tested this latter hypoth- 
esis using methanol (a smaller molecule than glycerol) as 
acceptor. It can be seen that similar results were obtained 
(Table 3). These last results, although they do not exclude 
the possibility that both glycerol and methanol hindered 
the water attack at the E-P covalent complex, they do 
agree with the hypothesis that cGMP enhances the rate of 
the E-P hydrolysis by directly acting on the limiting step 
of the catalytic process ( the water attack of the covalent 
0.50 1 
0.25 - AcPl 
0.00 -L- 
G -0.25 - 
-0.50 - 
-075 I I I 1 
215 240 265 290 315 
wavelength (nm) 
05- 
0.25 --i AcP2 
0.00 - 
: -0.25 - 
-0.50 - 
-0.75 ) I I I I 
215 240 265 290 315 
wavelength (nm) 
Fig. 3. Difference spectra of AcPl and AcP2 PTPase isoenzymes (17 
FM) in the presence of 0.1 mM cGMP. Spectra were recorded using a 
Beckman Model DU 7500 spectrophotometer. 
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Table 3 
Rat liver AcP2 isoenzyme: effect of cGMP on the transphosphorylation to glycerol and methanol. 
Addition to the assay mixture p-nitrophenol/Pi o/L’o 
None 1.01 + 0.02 1.00 + 0.02 
0.08 mM cGMP 0.97 * 0.02 1.50 + 0.03 
0.10 mM cGMP 0.99 + 0.01 1.74 + 0.03 
0.40 mM cGMP 0.96 + 0.02 3.10 f 0.06 
0.50 mM cGMP 1.03 f 0.03 3.51 * 0.0 
60.80 mM cGMP 1.05 + 0.02 4.32 + 0.05 
1 .OO mM cGMP 1.02 f 0.02 5.43 f 0.06 
1.0 M Glycerol 3.06 + 0.08 3.07 + 0.02 
1.0 M Glycerol + 0.10 mM cGMP 2.39 f 0.04 3.17 + 0.04 
1 .O M Glycerol + 0.50 mM cGMP 1.98 f 0.04 4.73 + 0.05 
1 .O M Glycerol + 1.00 mM cGMP 1.65 f 0.03 5.81 + 0.05 
1.0 M Methanol 1.91 + 0.04 1.90 + 0.02 
1.0 M Methanol + 0.08 mM cGMP 1.55 + 0.02 2.10 f 0.03 
1.0 M Methanol + 0.40 mM cGMP 1.32 f 0.03 3.56 f 0.03 
1.0 M Methanol + 0.80 mM cGMP 1.18 + 0.02 4.46 f 0.04 
All assays were performed using 8 mM p-nitrophenyl phosphate as substrate at 37°C and pH 5.5. u0 is the initial velocity measured in the absence of 
activators; u is the initial velocity measured in the presence of activators. 
complex thiol-phosphate bond >. This is clearly indicated 
by the decreasing p-nitrophenol/P, ratio at increasing 
cGMP concentrations in the presence of 1 M glycerol 
while the u/u0 ratio increases. The lower acceptor capabil- 
ity of glycerol in the presence of cGMP might be due to 
the lowering of the steady-state E-P concentration caused 
by the increased k,. 
The determination of the p-coefficients relative to other 
substrates (phenyl phosphate and 2-naphthyl phosphate) 
gave results that agree well with the hypothesis that cGMP 
increases the rate of dephosphorylation of the phospho- 
rylated enzyme-complex. In fact, p = 6.2 for phenyl 
phosphate and p = 5.9 for 2-naphthyl phosphate were 
found. These data are very close to the value of p = 6.1 
for p-nitrophenyl phosphate. Since there are structural 
differences among p-nitrophenyl phosphate, phenyl phos- 
phate and 2-naphthyl phosphate, the similarity of the p 
values indicates a common step (the dephosphorylation of 
the covalent complex) as the target of the cGMP action. 
In the cell cGMP is produced by both membrane-bound 
and soluble GMP cyclases. The former is strongly stimu- 
lated by some substances such as the atria1 natriuretic 
factor or the E. coli heat-stable enterotoxins, whereas the 
latter (a heme-containing enzyme) is strongly stimulated 
by nitric oxide [34]. Table 3 shows that 80 pM cGMP 
concentration causes 50%-activation of the AcP2 isoen- 
zyme in vitro. Although the mean cGMP concentration in 
the cell is lower than 80 PM, the local concentration in the 
sites of cGMP production may increase during activation 
of the cyclases, reaching levels able to stimulate the PT- 
Pase activity in vivo. 
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